Developmental Pathway Funding Scheme
Panel membership
- Professor R Alan North, Chair, Dean of the Faculty of Life Sciences, Dean of the Faculty of Medical and Human Sciences, The University of Manchester
- Professor Mimoun Azzouz, Sheffield Institute for Translational Neuroscience (SITraN), University of Sheffield
- Professor Andrew Baker, BHF Glasgow Cardiovascular Research Centre, University of Glasgow
- Professor Stuart Bevan, Department of Pharmacology and Therapeutics, King’s College London
- Dr Paul Brennan, SCG University of Oxford,
- Dr Gillian Burgess, UCB, Slough
- Professor Justin Bryans, Centre for Therapeutics Discovery, MRC Technology
- Dr Mike Dalrymple, MRC Technology
- Professor Ben Davis, Chemistry Research Laboratory, University of Oxford
- Dr Martin Drysdale, Beatson Institute for Cancer Research, Cancer Research UK
- Professor Alicia El Haj, Institute of Science and Technology in Medicine, Keele University
- Professor Marc Feldmann, Kennedy Institute of Rheumatology Division, Imperial College London
- Professor Anthony Gershlick, Cardiovascular Sciences Department, University Hospitals of Leicester
- Dr David Gray, College of Life Sciences, University of Dundee
- Dr Andy Grieve, Aptiv Solutions, Germany
- Dr Neil Gozzard, UCB Pharma, Slough
- Professor Jo Hajnal, Imaging Sciences Department, Imperial College London/MRC Clinical Sciences Centre
- Professor John Isaacs, Institute of Cellular Medicine, Newcastle University
- Professor Gordon Jayson, Department of Medical Oncology, University of Manchester
- Professor Simon Lovestone, Institute of Psychiatry, King’s College London
- Professor John Lunec, Northern Institute for Cancer Research, University of Newcastle
- Dr Adrian Mander, MRC Biostatistics Unit, Institute of Public Health
- Dr Raj Parekh, Advent Venture Partners
- Dr Tanya Parkinson, Pfizer
- Dr Richard Peck, Roche Products Ltd
- Dr John Pritchard, Smart Holograms Ltd
- Dr Mike Romanos, Crescendo Biologics Ltd
- Professor Jonathan Seckl, Centre for Cardiovascular Science, The University of Edinburgh
- Dr John Shields, Abingworth Management Ltd
- Professor David Shima, Institute of Ophthalmology, University College London
- Dr John Tite, Bicycle Therapeutics Ltd
- Professor Jonathan Weber, Faculty of Medicine, Imperial College London
- Dr Pauline Williams, GlaxoSmithKline
- Professor Matthew Wood, Physiology, Anatomy and Genetics, University of Oxford